Carvedilol and Perphenazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carvedilol (carvedilol) and Perphenazine (perphenazine). Common drug interactions include chronic kidney disease among females and angina pectoris among males.

The phase IV clinical study analyzes what interactions people have when they take Carvedilol and Perphenazine. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Carvedilol?

Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.

What is Perphenazine?

Perphenazine has active ingredients of perphenazine. It is often used in bipolar i disorder. eHealthMe is studying from 2,712 Perphenazine users. Check the latest studies of Perphenazine.



On Jul, 15, 2026

28 people who take Carvedilol and Perphenazine together, and have interactions are studied.

Carvedilol and Perphenazine drug interactions.

What are the common drug interactions of Carvedilol and Perphenazine, by gender? *:

female:

  1. Chronic kidney disease
  2. Pancreatic cyst
  3. Pancreatitis acute (sudden inflammation of pancreas)
  4. Death
  5. Genital prolapse (portion of the vaginal canal protruding (prolapsing) from the opening of the vagina)
  6. Insomnia (sleeplessness)
  7. Quality of life decreased
  8. Salivary hypersecretion (excess saliva secretion)
  9. Speech disorder
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

male:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Renal injury (kidney injury)
  4. Death
  5. Haemorrhage urinary tract (bleeding from uterine)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Pain in extremity
  8. Renal artery stenosis (narrowing of renal artery)
  9. Renal failure (kidney dysfunction)
  10. Renal tubular necrosis (death of kidney tubules)

What are the common drug interactions of Carvedilol and Perphenazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Chronic kidney disease
  5. Death
  6. Depression
  7. Emotional distress
  8. Pain
  9. Renal injury (kidney injury)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Decreased activity
  4. Depression
  5. Emotional distress
  6. Fatigue (feeling of tiredness)
  7. Pain
  8. Quality of life decreased
  9. Dry skin
  10. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)

60+:

  1. Chronic kidney disease
  2. Pancreatic cyst
  3. Cardiac arrest
  4. Cardiac failure congestive
  5. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  6. Fall
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Renal failure (kidney dysfunction)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Pancreatitis acute (sudden inflammation of pancreas)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 21.43%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 17.86%
  3. Type 2 Diabetes: 3 people, 10.71%
  4. Hiv Infection: 3 people, 10.71%
  5. Stress And Anxiety: 2 people, 7.14%
  6. Rashes (redness): 2 people, 7.14%
  7. Pain: 2 people, 7.14%
  8. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 7.14%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 7.14%
  10. High Blood Cholesterol: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Carvedilol and Perphenazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carvedilol and Perphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carvedilol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Perphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carvedilol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perphenazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on carvedilol and perphenazine (the active ingredients of Carvedilol and Perphenazine, respectively), and Carvedilol and Perphenazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: